Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 374

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 374
---
 and Debt, Closing Net Working Capital Amount and Unpaid Company Transaction Expenses within thirty (30) days of such
referral and upon reaching such determination shall deliver a copy of its calculations (the “Determination”) to the Stockholders Representative and TuHURA; and (C) the Determination made by the Accounting Firm of Closing Liabilities
and Debt, Closing Net Working Capital Amount and Unpaid Company Transaction Expenses shall be final and binding on TuHURA, the Surviving Company, the Stockholders Representative and the stockholders of the Company immediately prior to the Effective
Time, absent manifest error. The fees and expenses of the

235

Accounting Firm shall be borne by TuHURA and the Stockholders Representative (on behalf of the stockholders of the Company immediately prior to the Effective Time) in proportion to how close each party’s position was to the Determination of the Accounting Firm. Adjustments to Prevent Dilution If at any time during the period between the date of the Merger Agreement and the Effective Time, any change in the outstanding shares of capital stock of the Company, or securities convertible into or exchangeable into or exercisable for shares of such capital stock, shall occur as a result of any reclassification, recapitalization, stock split (including a reverse stock split) or subdivision or combination, exchange or readjustment of shares, or any stock dividend or stock distribution with a record date during such period, merger or other similar transaction, the Merger Consideration shall be equitably adjusted, without duplication, to reflect such change. Agreements relating to Kineta Stock Options and Kineta Warrants At the Effective Time:

| • |     | each In-the-Money Company Stock                                                                                                                                        
 Option that is vested or unvested and held by a Person will be entitled to exercise such In-the-Money Company Stock Option as set forth in the applicable Optionholder 
 Treatment Agreement and, upon such exercise, will be entitled to receive the Merger Consideration;                                                                     |

| • |     | each                                                                                                           
 Out-of-the-Money Company Stock Option held by a Person will be canceled and extinguished for no consideration; |

| • |     | the Pre-2023 Company Warrants will terminate upon their terms if such Pre-2023 Company Warrants are not previously exercised (if the Pre-2023 Company Warrants are exercised prior to the Effective Time, as a holder of shares of Kineta Common 
 Stock, the holder of such former Pre-2023 Company Warrants will be entitled to